Nuvectis Pharma Inc at H.C. Wainwright BioConnect Investor Conference Transcript
Okay. Welcome back to our next presentation. My name is Joe Pantginis. I'm the Director of Research and Managing Director here at the firm at H.C. Wainwright. Welcome to our Third Annual BioConnect Conference. Great to see everyone in person.
Our next presenter is Nuvectis. Presenting for the company is Ron Bentsur, Chief Executive Officer. I've known Ron for quite some time, especially at his time at Keryx, and really looking forward to hearing the story of one of our new covered companies with regard to their targeted oncology approaches. In fact, I'm hoping he's going to share some of the data that were produced independently from AstraZeneca that we think independently validated their approach here.
So looking forward to hearing the story, Ron. Thanks.
Thank you, Joe. I need to lower the microphone because Joe is about a 6'11. Thank you all for being here. It's a pleasure to be here. I want to thank H.C. Wainwright
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
